Investors > News Releases
Nov 12, 2018
Myriad to Present New Data from Its Industry-Leading Portfolio of Genetic Tests for Breast Cancer at the 2018 San Antonio Breast Cancer Symposium
Products
Nov 06, 2018
Myriad Genetics Reports Fiscal First-Quarter 2019 Financial Results
Financial
Nov 05, 2018
Myriad Receives the Prestigious 2018 Utah Top Workplaces Award
Corporate
Nov 02, 2018
Myriad Presents Two New Studies at the Western Section of the American Urological Association
Products
Oct 30, 2018
Myriad Genetics to Present at the Stephens New York Investment Conference
Financial
Oct 24, 2018
Myriad to Announce Fiscal First-Quarter 2019 Financial Results on November 6, 2018
Financial
Oct 23, 2018
Myriad Announces Publication of Foresight™ Carrier Screen Clinical Utility Study in Genetics in Medicine
Pipeline
Oct 22, 2018
Myriad’s BRACAnalysis CDx® Test Identifies Patients with Newly Diagnosed Advanced Ovarian Cancer Who May Benefit from Maintenance Treatment with Lynparza®
Products
Oct 19, 2018
New Studies Highlight Performance of Vectra® Test in Patients with Rheumatoid Arthritis Who Were Treated with Tofacitinib and Rituximab
Pipeline
Oct 18, 2018
Bendcare Endorses Vectra® Testing for Patients with Rheumatoid Arthritis
Products
Oct 16, 2018
Myriad Receives FDA Approval of BRACAnalysis CDx® as Companion Diagnostic for Pfizer’s TALZENNA® (talazoparib)
Products
Oct 10, 2018
Myriad Announces New Laboratory Agreement with Pfizer®
Products
Oct 09, 2018
Myriad and Pfizer Build Upon a Previously Announced Companion Diagnostic Agreement
Products
Oct 03, 2018
Myriad Genetics Announces Four Presentations at the 2018 American College of Rheumatology Annual Meeting
Products
Sep 26, 2018
Myriad Announces New GeneSight® Study Published in Personalized Medicine
Products